G1 Therapeutics, Inc. (GTHX) Marketable Securities, Current USD 2021 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of investment in marketable security, classified as current.
Summary
G1 Therapeutics, Inc. quarterly Marketable Securities, Current history and growth rate from 2021 to 2024.
  • G1 Therapeutics, Inc. Marketable Securities, Current for the quarter ending March 31, 2024 was $45.3 M, a 5.78% decline year-over-year.
Marketable Securities, Current, Quarterly (USD)
Marketable Securities, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $45.3 M -$2.78 M -5.78% Mar 31, 2024 10-Q 2024-05-01
Q4 2023 $49.9 M -$538 K -1.07% Dec 31, 2023 10-Q 2024-05-01
Q3 2023 $41.7 M +$12 M +40.3% Sep 30, 2023 10-Q 2023-11-01
Q2 2023 $48.3 M Jun 30, 2023 10-Q 2023-08-02
Q1 2023 $48.1 M Mar 31, 2023 10-Q 2023-05-03
Q4 2022 $50.5 M +$50.5 M Dec 31, 2022 10-K 2024-02-28
Q3 2022 $29.7 M Sep 30, 2022 10-Q 2022-11-02
Q4 2021 $0 Dec 31, 2021 10-K 2023-03-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.